Type: Cluster Project page: Access page Country: Italy Synopsis: The Clust-ER Health is an association made up of large companies, SMEs, laboratories of the High Technology Network, research centers, health facilities and training institutions that share skills, ideas and resources to support the competitiveness of the Health Industries and Wellness of Emilia-Romagna.
Type: Cluster Project page: Access page Country: Italy Synopsis: The Cluster supports the growth and promotion of life sciences in Tuscany, on the one hand fostering synergies, development opportunities and collaboration between the various actors of the sector (businesses, research centres, health system, other stakeholders) and on the other hand the consolidation of an aggregative...
Dates: 01/01/2020 31/12/2025 Topic: Biomarkers identification AI/Big Data DRUG Project type: Clinic Project target: Infectious Disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSIDAD CARLOS III DE MADRID Keywords: drug discovery; AI; diabetes; tuberculosis; oral drug; infectius disease; clinical trial Countries:...
Dates: 01/01/2020 31/12/2025 Topic: Biomarkers identification AI/Big data Project type: Preclinic Clinic Project target: Autoimmune disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.1. – Understanding health; wellbeing and disease Participating agents: FUNDACIO HOSPITAL UNIVERSITARI VALL D’HEBRON – INSTITUT DE RECERCA Keywords: rheumatology; autoimmunity; IMIDs; inflammatory bowel disease; biomarker; lupus; psoriasis...
Dates: 01/01/2021 31/12/2025 Topic: Tool Procedures Project type: Preclinic Project target: Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSITAETSKLINIKUM WUERZBURG – KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT Keywords: Countries: Germany; UK; Italy; France; Austria; Spain; Belgium; Luxembourg; Switzerland Project page: Access page...
Dates: 01/10/2020 31/12/2024 Topic: Tool AI/Big data Project type: Preclinic Clinic Theranostic Project target: Cervical Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.2. – Preventing disease Participating agents: STICHTING VUMC Keywords: screening; cervical cancer; tumour; HPV; cytology; DNA; e-health; vaccine; clinical trial Countries: Netherlands; Sweden; France; Finland; Spain; Belgium; Slovenia;...
Dates: 01/06/2021 31/05/2026 Topic: Biomarkers identification Tool Project type: Preclinic Theranostic Project target: Prostate Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: POLITECNICO DI TORINO Keywords: liquid biopsy; biomarker; cancer; influenza A; RNA; nano-material; machine-learning; SERS; surface enhanced Raman scattering; nano particles Countries: Italy Project page: Access page
Dates: 01/01/2021 31/12/2024 Topic: Tool Project type: Preclinic Theranostic Project target: Prostate Cancer Financing: H2020-EU.1.3. – EXCELLENT SCIENCE – Marie Sk?odowska-Curie Actions H2020-EU.1.3.3. – Stimulating innovation by means of cross-fertilisation of knowledge Participating agents: DESTINA GENOMICA SLNE OPTOELETTRONICA ITALIA SRL UNIVERSITA DEGLI STUDI DI CATANIA UNIVERSITA DEGLI STUDI DI TRENTO PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE...
Dates: 01/06/2021 31/05/2028 Topic: Procedures Project type: Clinic Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM Keywords: tuberculosis; drug resistance; machine learning; microbiology; simulation software; tool; procedure; clinical trial; biomarker Countries: Netherlands; UK;...
Dates: 01/01/2020 31/12/2024 Topic: Biomarkers identification Project type: Preclinic Clinic Immunotherapy Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Other Participating agents: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Keywords: hepatitis B; vaccine; CHB; biomarker; clinical trial; public health;...